Alessandra Bosch: Von Willebrand Disease and Rare Bleeding Disorders, Collaborative Insights and Patient Empowerment
Alessandra Bosch, Clinician Scientist at University of Zurich, shared a post on LinkedIn:
“Such an inspiring Saturday at the Von Willebrand Disease and Rare Bleeding Disorders Patient Day (SHG) in Bern a full day dedicated to von Willebrand disease and rare bleeding disorder patients, held in German and French with simultaneous translation.
It was great to share the stage with colleagues AlessandroCasini (HUG) on new treatments and therapies for rare bleeding disorders, and Sebastien L. (HUG, UCLouvain) on the role of physiotherapy and joint assessment in Von Willebrand disease, including a hands on ultrasound workshop.
I had the pleasure of presenting on bleeding symptoms in women and girls with bleeding disorders, and giving a workshop on heavy menstrual bleeding in adolescents young women.
Thank you to the Swiss Haemophilia Society for organizing such a valuable event for the bleeding disorders community.
And a big THANKS to the patients for your active participation!”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient
-
Oct 9, 2026, 07:21Federico Ravaioli: 40 kPa Spleen Stiffness May Help Avoid Endoscopy in Chronic PVT
-
Oct 9, 2026, 07:00Danny Reardon: Closing the Global Awareness Gap on Blood Clots
-
Oct 9, 2026, 00:54Mary Catherine Moffett: Advancing Advocacy Together – Highlights from the Sanofi Bleeding Disorders Summit